Impact Of Smoking Cessation Treatment Reimbursement On The Quit Rates In Smokers Motivated To Quit (ACCESSATION)

Pfizer

Status and phase: Completed; Phase 4

Conditions: Insurance Coverage; Smoking Cessation

Treatments: Other: Full Smoking Cessation Treatment Coverage (100%); Other: No Smoking Cessation Treatment Coverage (0%)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00818207

A3051116

Details and patient eligibility

About

This study is based on the hypothesis that access to smoking cessation treatment (SCT) reimbursement may significantly increase the number of successful quitters in a population of smokers motivated to quit by: 1) increasing the use of SCTs in quit attempts, and 2) by improving subject adherence to treatment.

Enrollment: 1,380 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Daily smokers (10 cigarettes per day or more);
• Smokers motivated to make a quit attempt within the next 14 days;
• Potential subjects must be outpatients;
• A subject must have a stable mental and physical medical condition (as per investigator's judgment).

Exclusion criteria

• A subject currently eligible for smoking cessation treatment (SCT) reimbursement, whether from a public or a private drug insurance;
• A subject with an unknown drug insurance status;
• A subject living in a household where there is someone already recruited in the study;
• A subject with an unfilled SCT prescription issued within the past three months or with an unused SCT product;
• A subject with a life-threatening illness (ie, known or suspected cancer or other disease with a life expectancy of less than one year).

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

1,380 participants in 2 patient groups

Full Smoking Cessation Treatment Coverage (100%)

Other group

Description:

A subject randomized to the intervention group will be eligible for smoking cessation treatment (SCT) reimbursement during the 26-week period following the randomization.

Treatment:

Other: Full Smoking Cessation Treatment Coverage (100%)

No Smoking Cessation Treatment Coverage (0%)

Other group

Description:

Subjects in the control group choosing to quit using an SCT method will not be eligible for smoking cessation treatment (SCT) reimbursement and, thus, will have to purchase their treatment out of pocket.

Treatment:

Other: No Smoking Cessation Treatment Coverage (0%)